Answers are grounded in this paper and cite their sources.
This commentary reviews the evolution of the process of cancer research in the United States over the past 6 decades, from an academic‐based to drug industry‐based research, and the advantages and concerns. It proposes a new form of cancer research that involves the tumor‐specific cancer researchers as the primary drivers of the process, and outlines the benefits of such a model in relation to potential improved cost benefits, success rates, and research time lines.
No takes yet. Share an insight, caveat, or question.
Kantarjian et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: